Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2025
Human alveolar echinococcosis-global, regional, and national annual incidence and prevalence rates.
СтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Lundström-Stadelmann Britta, Rostami Ali, Frey Caroline F, Torgerson Paul R, Riahi Seyed Mohammad, Bagheri Kimia, Kaethner Marc, Lachenmayer Anja, Beldi Guido, Gasser Robin B, Hemphill Andrew
Аннотация
BACKGROUND: Alveolar echinococcosis (AE) of humans is a disease caused by the larval (metacestode) stage of the 'fox tapeworm' Echinococcus multilocularis. AE primarily affects the liver and, like cancer, can spread to surrounding or distant organs. Its slow progression and resemblance to malignant tumours emphasise the critical importance of early detection and intervention, as there is no highly effective vaccine against AE. Although recognised as a neglected disease, there has been no recent, comprehensive review of the distribution, incidence and prevalence of AE in humans around the world.
OBJECTIVES: To estimate the global, regional, and national annual incidence rates and prevalences of human AE in endemic countries.
SOURCES: Incidence and prevalence data were obtained from published articles from 1980 to 2024, accessible via public databases.
CONTENT: This article provides a brief background on E. multilocularis, its biology and impact; reviews the geographic distribution and incidence of AE; and gives a perspective on the prevention and control of this neglected disease in humans.
IMPLICATIONS: The AE burden in humans is substantial and emphasises the need for enhanced public awareness, surveillance, prevention, and control, particularly in under-resourced communities to mitigate the health, economic, and psychological impact of AE.
OBJECTIVES: To estimate the global, regional, and national annual incidence rates and prevalences of human AE in endemic countries.
SOURCES: Incidence and prevalence data were obtained from published articles from 1980 to 2024, accessible via public databases.
CONTENT: This article provides a brief background on E. multilocularis, its biology and impact; reviews the geographic distribution and incidence of AE; and gives a perspective on the prevention and control of this neglected disease in humans.
IMPLICATIONS: The AE burden in humans is substantial and emphasises the need for enhanced public awareness, surveillance, prevention, and control, particularly in under-resourced communities to mitigate the health, economic, and psychological impact of AE.